Bazedoxifene analogs as potential WDHD1 degraders and antitumor agents: Synthesis, evaluation and molecular dynamics simulation studies
作者:Leyuan Chen、Gaiting Liu、Fancui Meng、Yu shi、Zhennan Fang、Zhenyu Peng、Manjiang Wang、Wenfeng Gou、Wenbin Hou、Yiliang Li
DOI:10.1002/ddr.22155
日期:2024.2
rate on WDHD1 in MCF7 cells at 10 μM, from the Food and Drug Administration-approved compound library. Here, we initially established the binding model of BZA, synthesized and evaluated eight BZA analogs. Further, we detailed the use of molecular dynamics simulations to provide insights into the basis for activity against WDHD1. This binding mode will be instructive for the development of new WDHD1
DNA修复与肿瘤对放疗和化疗的抵抗力密切相关。 WD重复序列和HMG-box DNA结合蛋白1(WDHD1)是DNA同源重组修复的关键接头,其过度表达与许多肿瘤患者的不良预后有关。我们之前从食品和药物管理局批准的化合物库中鉴定并验证了巴多昔芬 (BZA),10 μM 时,它对 MCF7 细胞中的 WDHD1 具有 60% 的抑制率。在这里,我们初步建立了BZA的结合模型,合成并评估了八种BZA类似物。此外,我们详细介绍了分子动力学模拟的使用,以深入了解针对 WDHD1 的活性基础。这种结合模式对于新型 WDHD1 降解剂的开发具有指导意义。